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Data for Rare Diseases are often distributed. Ideally, we
can combine relevant data and biological insights from
any place in the world and use it directly as input for com-
putational analysis. However, too often data is poorly
described making it hard to find, hard to assess its quality,
and hard to integrate with other data. A valid question is:
‘Why can’t we analyse data as if it came from one global
database?’. Here we introduce the Semantic Web as an
enabling technology for making data interoperable and
thereby expediting biological insight.
The Semantic Web ‘language’ is RDF: the Resource
Description Framework. It uses the ‘hyperlink’ mechanism
known from the internet to refer to data instead of web
pages. Meaningful relations are specified as triples: subject,
predicate, object. For example, ‘CAPN3’, ‘interacts with’,





While RDF is meant for computers, we see that: (i) RDF
triples convey meaning; (ii) hyperlinks specify the location
of data, which might be different databases (even within a
triple); (iii) data items are also references to other RDF
documents with more triples (e.g. try http://www.uniprot.
org/uniprot/Q13547 in a browser). A hyperlink can be in
any number of triples, effectively creating the world wide
database of meaningfully linked data that is needed in the
study of Rare Diseases. Ontologies can also be encoded in
RDF, thereby extending the functionality to a global
knowledge base. New experiments and discoveries can
continually add information to this knowledge base.
For example, the Semantic Web can help us to find
drug targets for Rare Diseases. For this purpose, Open-
Phacts [1] is integrating compounds from Chemspider
[http://chemspider.com], proteins from UniProt [http://
uniprot.org], pathways from WikiPathways [http://wiki-
pathways.org], and documents from PubMed [http://
www.ncbi.nlm.nih.gov/pubmed/]. We also make DNA
sequence variations from the Leiden Open Variation
Database (LOVD [http://www.lovd.nl]) available in RDF,
and visualised via the UCSC genome browser.
However, a number of barriers must be overcome. First,
databases pre-dating the Semantic Web are used abun-
dantly and must be integrated. This is usually an expensive
and tedious task. Secondly, building a scientific reputation
often conflicts with data sharing. Therefore, we have
developed a data publishing framework called Nanopubli-
cation: an application of RDF that links authorship to indi-
vidual datum (attribution). This creates a transparent and
equitable incentive for data sharing. Nano publications
also provide incentives for the exposure of legacy data.
In conclusion, Nano publications and Semantic Web
technology makes data easier to find and directly applic-
able to integrative analyses.
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